Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling

Biochemical Pharmacology

Volumn 64, Issue 5-6, 2002, Pages 755-763

  Pouysségur, Jacques ^a   Volmat, Véronique ^a   Lenormand, Philippe ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Cell trafficking; MAP kinases; MAPK phosphatases; Nucleus; Scaffolding proteins

Indexed keywords

DNA; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; PROTEASOME; PROTEIN KINASE; PROTEIN TYROSINE KINASE; RAS PROTEIN; UBIQUITIN;

ACCURACY; ARTICLE; AUTOREGULATION; CELL ASSAY; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CELL STIMULATION; CELLULAR DISTRIBUTION; CYTOPLASM; DEGRADATION; DNA REPLICATION; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME REGULATION; HUMAN; INTRACELLULAR TRANSPORT; MITOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ANIMALS; CELL NUCLEUS; ENZYME ACTIVATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORIC MONOESTER HYDROLASES; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

EID: 0036709020     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01135-8     Document Type: Article

References (61)

1. Tanoue T., Adachi M., Moriguchi T., Nishida E. A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat. Cell. Biol. 2(2):2000;110-116.
2. Brondello J.M., Pouysségur J., McKenzie F.R. Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science. 286(5449):1999;2514-2517.
3. Brunet A., Roux D., Lenormand P., Dowd S., Keyse S., Pouysségur J. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO. J. 18(3):1999;664-674.
4. Volmat V., Camps M., Arkinstall S., Pouysségur J., Lenormand P. The nucleus, a site for signal termination by sequestration and inactivation of p42/p44 MAP kinases. J. Cell. Sci. 114:2001;3433-3443.
5. Pagès G., Guerin S., Grall D., Bonino F., Smith A., Anjuere F., Auberger P., Pouysségur J. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science. 286(5443):1999;1374-1377.
6. Widmann C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79(1):1999;143-180.
7. Kerkhoff E., Rapp U.R. The Ras-Raf relationship: an unfinished puzzle. Adv. Enzyme Regul. 41:2001;261-267.
8. Hallberg B., Rayter S.I., Downward J. Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation. J. Biol. Chem. 269(6):1994;3913-3916.
9. Lewis T.S., Shapiro P.S., Ahn N.G. Signal transduction through MAP kinase cascades. Adv. Cancer. Res. 74:1998;49-139.
10. Pagès G., Lenormand P., L'Allemain G., Chambard J.-C., Méloche S., Pouysségur J. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 90:1993;8319-8323.
11. Lavoie J.N., Rivard N., L'Allemain G., Pouysségur J. A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry. Prog. Cell Cycle Res. 2:1996;49-58.
12. Whitmarsh A.J., Davis R.J. A central control for cell growth. Nature. 403(6767):2000;255-256.
13. Formstecher E., Ramos J.W., Fauquet M., Calderwood D.A., Hsieh J.C., Canton B., Nguyen X.T., Barnier J.V., Camonis J., Ginsberg M.H., Chneiweiss H. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev. Cell. 1(2):2001;239-250.
14. Traverse S., Gomez N., Paterson H., Marshall C., Cohen P. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Biochem. J. 288:1992;351-355.
15. Kahan C., Seuwen K., Méloche S., Pouysségur J. Coordinate, biphasic activation of p44 mitogen activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. J. Biol. Chem. 267:1992;13369-13375.
16. Le Gall M., Chambard J.-C., Breittmayer J.P., Grall D., Pouysségur J., Van Obberghen-Schilling E. The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal. Mol. Biol. Cell. 11(3):2000;1103-1112.
17. Zugasti O., Rul W., Roux P., Peyssonnaux C., Eychene A., Franke T.F., Fort P., Hibner U. Raf-MEK-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt. Mol. Cell Biol. 21(19):2001;6706-6717.
18. Whitmarsh A.J., Davis R.J. Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. Trends Biochem. Sci. 23(12):1998;481-485.
19. Elion E.A. The Ste5p scaffold. J. Cell Sci. 114(Pt 22):2001;3967-3978.
20. Pryciak P.M. MAP kinases bite back. Dev. Cell. 1(4):2001;449-451.
21. van Drogen F., Stucke V.M., Jorritsma G., Peter M. MAP kinase dynamics in response to pheromones in budding yeast. Nat. Cell Biol. 3(12):2001;1051-1059.
22. Mahanty S.K., Wang Y., Farley F.W., Elion E.A. Nuclear shuttling of yeast scaffold Ste5 is required for its recruitment to the plasma membrane and activation of the mating MAPK cascade [in process citation]. Cell. 98(4):1999;501-512.
23. Schaeffer H.J., Catling A.D., Eblen S.T., Collier L.S., Krauss A., Weber M.J. MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade [see comments]. Science. 281(5383):1998;1668-1671.
24. Wunderlich W., Fialka I., Teis D., Alpi A., Pfeifer A., Parton R.G., Lottspeich F., Huber L.A. A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold mp1 on a late endosomal/lysosomal compartment. J. Cell Biol. 152(4):2001;765-776.
25. Therrien M., Chang H.C., Solomon N.M., Karim F.D., Wassarman D.A., Rubin G.M. KSR, a novel protein kinase required for Ras signal transduction. Cell. 83(6):1995;879-888.
26. Morrison DK. KSR: A MAPK scaffold of the Ras pathway? J Cell Sci 2001;114(Pt 9):1609-12.
27. Muller J., Ory S., Copeland T., Piwnica-Worms H., Morrison D.K. C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1. Mol. Cell. 8(5):2001;983-993.
28. Bardwell L., Thorner J. A conserved motif at the amino termini of MEKs might mediate high affinity interaction with the cognate MAPKs. Trends Biochem. Sci. 21:1996;373-374.
29. Tanoue T., Maeda R., Adachi M., Nishida E. Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions. EMBO J. 20(3):2001;466-479.
30. Tarrega C., Blanco-Aparicio C., Munoz J.J., Pulido R. Two clusters of residues at the docking groove of mitogen-activated protein kinases differentially mediate their functional interaction with the tyrosine phosphatases PTP-SL and STEP. J. Biol. Chem. 277(4):2002;2629-2636.
31. Sharrocks A.D., Yang S.H., Galanis A. Docking domains and substrate-specificity determination for MAP kinases. Trends Biochem. Sci. 25(9):2000;448-453.
32. Bardwell A.J., Flatauer L.J., Matsukuma K., Thorner J., Bardwell L. A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission. J. Biol. Chem. 276(13):2001;10374-10386.
33. Yang S.H., Yates P.R., Whitmarsh A.J., Davis R.J., Sharrocks A.D. The Elk-1 ETS-domain transcription factor contains a mitogen-activated protein kinase targeting motif. Mol. Cell. Biol. 18(2):1998;710-720.
34. Fukuda M, Gotoh Y, Nishida E. Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase, EMBO J 1997;1901-8.
35. Blanco-Aparicio C., Torres J., Pulido R. A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase. J. Cell Biol. 147(6):1999;1129-1136.
36. Fantz D.A., Jacobs D., Glossip D., Kornfeld K. Docking sites on substrate proteins direct extracellular signal-regulated kinase to phosphorylate specific residues. J. Biol. Chem. 276(29):2001;27256-27265.
37. Fukuda M., Gotoh I., Gotoh Y., Nishida E. Cytoplasmic localization of MAP kinase kinase directed by its N-terminal, leucin-rich amino acid sequence, which acts as a nuclear export signal. J. Biol. Chem. 271:1996;20024-20028.
38. Posada J., Cooper J.A. Requirements for phosphorylation of MAP kinase during meiosis in xenopus oocytes. Science. 255:1992;212-215.
39. Alessi D., Gomez N., Moorhead G., Lewis T.S., Keyse S.M., Cohen P. Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Curr. Biol. 5:1995;283-295.
40. Sohaskey M.L., Ferrell J.E. Jr. Distinct, constitutively active MAPK phosphatases function in Xenopus oocytes: implications for p42 MAPK regulation in vivo. Mol. Biol. Cell. 10(11):1999;3729-3743.
41. Oh-hora M., Ogata M., Mori Y., Adachi M., Imai K., Kosugi A., Hamaoka T. Direct suppression of TCR-mediated activation of extracellular signal-regulated kinase by leukocyte protein tyrosine phosphatase, a tyrosine-specific phosphatase. J. Immunol. 163(3):1999;1282-1288.
42. Pettiford S.M., Herbst R. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP. Oncogene. 19(7):2000;858-869.
43. Karim F.D., Rubin G.M. PTP-ER, a novel tyrosine phosphatase, functions downstream of Ras1 to downregulate MAP kinase during Drosophila eye development. Mol. Cell. 3(6):1999;741-750.
44. Brondello J.M., Brunet A., Pouysségur J., McKenzie F.R. The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J. Biol. Chem. 272(2):1997;1368-1376.
45. Camps M., Nichols A., Arkinstall S. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB. J. 14(1):2000;6-16.
46. Keyse S.M. Protein phosphatases, the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12(2):2000;186-192.
47. Camps M., Nichols A., Gillieron C., Antonsson B., Muda M., Chabert C., Boschert U., Arkinstall S. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase [see comments]. Science. 280(5367):1998;1262-1265.
48. Slack D.N., Seternes O.M., Gabrielsen M., Keyse S.M. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1. J. Biol. Chem. 276(19):2001;16491-16500.
49. Dorfman K., Carrasco D., Gruda M., Ryan C., Lira S.A., Bravo R. Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene. 13(5):1996;925-931.
50. Lenormand P., Sardet C., Pagès G., L'Allemain G., Brunet A., Pouysségur J. Growth factors induce nuclear translocation of MAP kinases (p42maPk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J. Cell. Biol. 122:1993;1079-1089.
51. Traverse S., Seedorf K., Paterson H., Marshall C., Cohen P., Ullrich A. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr. Biol. 4:1994;694-701.
52. Robinson M.J., Stippec S.A., Goldsmith E., White M.A., Cobb M.H. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr. Biol. 8(21):1998;1141-1150.
53. Kim-Kaneyama J., Nose K., Shibanuma M. Significance of nuclear relocalization of ERK1/2 in reactivation of c-fos transcription and DNA synthesis in senescent fibroblasts. J. Biol. Chem. 275(27):2000;20685-20692.
54. Tohgo A., Pierce K.L., Choy E.W., Lefkowitz R.J., Luttrell L.M. Beta-arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK mediated transcription following angiotensin AT1a receptor stimulation. J. Biol. Chem. 2:2002;2.
55. Lenormand P., Brondello J.M., Brunet A., Pouysségur J. Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins. J. Cell. Biol. 142(3):1998;625-633.
56. Khokhlatchev A.V., Canagarajah B., Wilsbacher J., Robinson M.J., Atkinson M., Goldsmith E., Cobb M.H. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell. 93:1998;605-615.
57. Matsubayashi Y., Fukuda M., Nishida E. Evidence for existence of a nuclear pore complex-mediated, cytosol-independent pathway of nuclear translocation of ERK MAP kinase in permeabilized cells. J. Biol. Chem. 276(45):2001;41755-41760.
58. Volmat V., Pouysségur J. Spatiotemporal regulation of the p42/p44 MAPK pathway. Biol. Cell. 93(1-2):2001;71-79.
59. Adachi M., Fukuda M., Nishida E. Two co-existing mechanisms for nuclear import of MAP kinase: passive diffusion of a monomer and active transport of a dimer. EMBO. J. 18(19):1999;5347-5358.
60. Lorenzen J.A., Baker S.E., Denhez F., Melnick M.B., Brower D.L., Perkins L.A. Nuclear import of activated D-ERK by DIM-7, an importin family member encoded by the gene moleskin. Development. 128(8):2001;1403-1414.
61. Adachi M., Fukuda M., Nishida E. Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism [published erratum appears in J Cell Biol 2000 May 1;149(3):754]. J. Cell. Biol. 148(5):2000;849-856.